PYCR1, on the other hand, has been included in a metabolism-related gene signature and has been shown to regulate glutamine metabolism, thereby constructing an immunosuppressive microenvironment that facilitates ccRCC progression [37,38]. Here, PYCR1 is linked to nonpapillary renal cell carcinoma.